L. Zuckerman

发表

Negative regulation of CD4 lineage development and responses by CD5.

A. Tarakhovsky, N. Killeen, W. Ferris, 1999, Journal of immunology.

Recommendations for the design and optimization of immunoassays used in the detection of host antibodies against biotechnology products.

George Scott, Viswanath Devanarayan, Gopi Shankar, 2004, Journal of immunological methods.

Expression and functional significance of an additional ligand for CTLA-4.

J. Bluestone, D. Lenschow, G. Su, 1993, Proceedings of the National Academy of Sciences of the United States of America.

Determination of the tyrosine phosphorylation sites in the T cell transmembrane glycoprotein CD5.

N. Killeen, W. Ferris, K. Dennehy, 2001, International immunology.

Development and Responses by CD5 Negative Regulation of CD4 Lineage

N. Killeen, C. Peña-Rossi, L. Zuckerman, 1999 .

The CD28 ligand, B7, enhances IL-2 production by providing a costimulatory signal to T cells.

J. Miller, M. Jenkins, K. Urdahl, 1992, Journal of immunology.

Safety and Efficacy of a Novel, Dry Powder Fibrin Sealant for Hemostasis in Hepatic Resection

J. D. de Wilt, R. Porte, L. Zuckerman, 2014, Digestive Surgery.

Identification of a unique costimulatory activity for murine T helper 1 T cell clones.

J. Miller, A. Sant, L. Zuckerman, 1995, Journal of immunology.

Inhibition of transplant rejection following treatment with anti-B7-2 and anti-B7-1 antibodies.

G. Freeman, J. Bluestone, D. Lenschow, 1995, Transplantation.

Heterobimetallic {PtMn} and {PtFe} lantern complexes with exceptionally long metallophilic contacts

M. P. Shores, A. Rheingold, L. Doerrer, 2019, Inorganica Chimica Acta.

The FINISH-3 trial: a phase 3, international, randomized, single-blind, controlled trial of topical fibrocaps in intraoperative surgical hemostasis.

P. Pattyn, G. Bochicchio, R. Troisi, 2015, Journal of the American College of Surgeons.

Preclinical safety of recombinant human thrombin.

Erika Giste, R. Ponce, S. Pederson, 2007, Regulatory toxicology and pharmacology : RTP.

Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology products.

Viswanath Devanarayan, Michele Fiscella, Lakshmi Amaravadi, 2008, Journal of pharmaceutical and biomedical analysis.

Safety and pharmacokinetics of recombinant factor XIII in healthy volunteers

M. Butine, L. Zuckerman, J. Visich, 2005, Thrombosis and Haemostasis.

Thiolate-Thione Redox-Active Ligand with a Six-Membered Chelate Ring via Template Condensation and Its Pt(II) Complexes.

A. Rheingold, L. Doerrer, L. Zuckerman, 2021, Inorganic chemistry.

Recommendations on risk-based strategies for detection and characterization of antibodies against biotechnology products.

Viswanath Devanarayan, Boris Gorovits, Michael Moxness, 2008, Journal of immunological methods.

Functional consequences of costimulation by ICAM-1 on IL-2 gene expression and T cell activation.

J. Miller, Jim Miller, L. Zuckerman, 1998, Journal of immunology.

Immune responses to therapeutic proteins in humans--clinical significance, assessment and prediction.

A. Mire-Sluis, E Koren, L. Zuckerman, 2002, Current pharmaceutical biotechnology.

Randomized trial of a dry-powder, fibrin sealant in vascular procedures.

G. Moneta, P. Hayes, I. Chetter, 2015, Journal of vascular surgery.

Fibrocaps for surgical hemostasis: two randomized, controlled phase II trials.

C. Verhoef, N. Singla, R. Porte, 2015, The Journal of surgical research.